Helminths, allergic disorders and IgE-mediated immune responses: Where do we stand?

被引:52
|
作者
Erb, Klaus J. [1 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Dept Pulm Res, D-88397 Bilberach Riss, Germany
关键词
allergy; helminths; IgE; mast cells;
D O I
10.1002/eji.200737314
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Th2 responses induced by allergens or helminths share many common features. However, allergen-specific IgE can almost always be detected in atopic patients, whereas helminth-specific IgE is often not detectable and anaphylaxis often occurs in atopy but not helminth infections. This may be due to T regulatory responses induced by the helminths or the lack of helminth-specific IgE. Alternatively non-specific IgE induced by the helminths may protect from mast cell or basophil degranulation by saturating IgE binding sites. Both of these mechanisms have been implicated to be involved in helminth-induced protection from allergic responses. An article in the current issue of the European Journal of Immunology describes the generation of an antiNippostrongylus brasiliensis-specific IgE antibody which was used to identify a novel N. brasiliensis antigen (Nb-Ag1). The authors demonstrated that Nb-Ag1 specific IgE could only be detected for a short period of time during infection, and that these levels were sufficient to prime mast cells thereby leading to active cutaneous anaphylaxis after the application of Nb-Ag1. This is the first report clearly showing that a low level of helminth-specific IgE, transiently produced, is able to induce mast cell degranulation in the presence of large amounts of polyclonal IgE.
引用
收藏
页码:1170 / 1173
页数:4
相关论文
共 50 条
  • [41] Relationship between omalizumab pharmacokinetics, IgE pharmacodynamics and symptoms in patients with severe persistent allergic (IgE-mediated) asthma
    Lowe, Philip J.
    Tannenbaum, Stacey
    Gautier, Aurelie
    Jimenez, Pablo
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (01) : 61 - 76
  • [42] Prior Exposure to Ortho-Phthalaldehyde Augments IgE-Mediated Immune Responses to Didecyldimethylammonium Chloride: Potential for 2 Commonly Used Antimicrobials to Synergistically Enhance Allergic Disease
    Shane, Hillary L.
    Lukomska, Ewa
    Weatherly, Lisa
    Baur, Rachel
    Anderson, Stacey E.
    TOXICOLOGICAL SCIENCES, 2020, 178 (01) : 127 - 137
  • [43] Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
    Ko, Emily
    Chehade, Mirna
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 55 (02) : 205 - 216
  • [44] Peptide-based vaccination:: where do we stand?
    Francis, JN
    Larché, M
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 5 (06) : 537 - 543
  • [45] Mouse Models for Food Allergies: Where Do We Stand?
    Schuelke, Stefan
    Albrecht, Melanie
    CELLS, 2019, 8 (06)
  • [46] Cytokines and irritable bowel syndrome: Where do we stand?
    Bashashati, Mohammad
    Rezaei, Nima
    Andrews, Christopher N.
    Chen, Chun-Qiu
    Daryani, Nasser Ebrahimi
    Sharkey, Keith A.
    Storr, Martin A.
    CYTOKINE, 2012, 57 (02) : 201 - 209
  • [47] The suppressive effect of dabrafenib, a therapeutic agent for metastatic melanoma, in IgE-mediated allergic inflammation
    Choi, Young-Ae
    Lee, Soyoung
    Choi, Jin Kyeong
    Kang, Byeong-Cheol
    Kim, Min-Jong
    Dhakal, Hima
    Kwon, Taeg Kyu
    Khang, Dongwoo
    Kim, Sang-Hyun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83
  • [48] Cow's Milk Allergy: Where do we Stand?
    Priftis, Kostas N.
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2014, 14 (01) : 1 - 1
  • [49] Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
    Emily Ko
    Mirna Chehade
    Clinical Reviews in Allergy & Immunology, 2018, 55 : 205 - 216
  • [50] Repositioning of anti-cancer drug candidate, AZD7762, to an anti-allergic drug suppressing IgE-mediated mast cells and allergic responses via the inhibition of Lyn and Fyn
    Park, Young Hwan
    Kim, Do-Kyun
    Kim, Hyun Woo
    Kim, Hyuk Soon
    Lee, Dajeong
    Lee, Min Burn
    Min, Keun Young
    Koo, Jimo
    Kim, Jeong
    Kang, Changhee
    Kim, Young Mi
    Kim, Hyung Sik
    Choi, Wahn Soo
    BIOCHEMICAL PHARMACOLOGY, 2018, 154 : 270 - 277